Morningstar (NASDAQ:MORN) beats Q3 2026 sales expectations

Morningstar (MORN) reported Q3 2026 revenue of $672.1M, up 8.9% YoY, beating estimates by 1.3%. Non-GAAP EPS was $3.48, 14.5% above consensus. The company launched Direct AI and saw strong adoption of its MCP offerings. Shares fell 3.6% post-results.

Original reporting
Published Oct 28, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morningstar (NASDAQ:MORN) beats Q3 2026 sales expectations — source image
Decision brief

The 30-second read

$MORNBearishMed
01

Why it matters

The earnings beat was modest and the stock fell, suggesting investors are cautious about future growth despite AI product launches.

02

Market read

Morningstar's earnings release provides fresh data for sector analysts and may influence short‑term trading in the financial data services space.

03

What to watch

The launch of Direct AI and rising tool calls could drive longer‑term revenue growth not reflected in the short‑term price move.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Morningstar is a leading investment research firm; its earnings are closely watched by analysts covering the financial data sector.

Company-level read

Ticker impact

$MORNBearishHigh confidence
Context

Morningstar reported Q3 2026 revenue and EPS beats, with shares down 3.6% after the release.

Expected impact

likely downward pressure as the market prices in the modest beat and guidance uncertainty

Evidence & confidence

The earnings beat was modest and the stock fell 3.6% on the news, indicating traders may sell on perceived lack of upside.

Market effects

Provides a data point on the financial data‑services sector's growth trajectory.

Limited to U.S. equity markets; no broader regional effect.

Minor global relevance; primarily of interest to investors in financial information providers.

Counterpoint

Despite the beat, the stock may be undervalued if AI‑driven product adoption accelerates.

Key entities

  • Morningstar

    Investment research firm reporting Q3 2026 results.

  • Kunal Kapoor

    CEO of Morningstar who commented on product enhancements.

Related articles

$MORNMed

Morningstar, Inc. Reports Third-Quarter 2026 Financial Results

Morningstar, Inc. (MORN) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release 22 West Washington Street Telephone: +1 312 696-6000 Chicago Facsimile: +1 312 696-6009 Illinois 60602 FOR IMMEDIATE RELEASE Morningstar, Inc. Reports Third-Quarter 2026 Financial Results CHICAGO, Oct. 28, 2026 - Morningstar, Inc. (Nasdaq: MORN) reported growth in re

$MORNMed

Profit per share rose 41% at Morningstar to $3.06 in Q3.

Morningstar reported a 41% increase in Q3 profit per share to $3.06, with revenue up 8.9% to $672.1M. CEO Kunal Kapoor highlighted product enhancements and strong adoption of AI-driven tools. Year-to-date revenue rose 9.7% to $2.0B, with net income per share up 41.6% to $8.61. The company repurchased $100M in shares during Q3 and $500M year-to-date.

High

SPCX Stock Jumps 10% Premarket: Morningstar Boosts SpaceX’s Fair Value As Starship And Orbital AI Offer Long-Term Upside

SpaceX (SPCX) stock rose 10% premarket after Morningstar increased its fair value estimate to $70 from $62, citing Starship reusability and orbital AI potential. Analyst Nicolas Owens highlighted SpaceX's strong market position, high launch volume, and cost advantages. CEO Elon Musk projected $1T revenue by 2028, up from prior estimates. Retail sentiment turned 'extremely bullish'. SPCX is down 8% YTD.

$DKNGMed

Morningstar: DraftKings Trading Well Below Fair Value Estimate

DraftKings (DKNG) shares are down 40% YTD, but Morningstar analyst Dan Wasiolek argues the stock is undervalued, with a $39 fair value estimate. Despite regulatory uncertainty, Morningstar rates it five stars, forecasting 8.1% sales and 24.9% EBITDA growth from 2026-2035. The NBA's crackdown on player proposition markets is not expected to hinder sports betting demand.